13 October 2010 – trading update
An encouraging statement from this medical diagnostics company has shown that trading is in line with expectations with turnover up 15% at £3.3m for the six months to 30 September. The group continues to examine acquisition opportunities which we feel are key to driving value into the business and we continue to rate the shares a LONG TERM BUY.